Sleep Aids - LATAM

  • LATAM
  • Revenue in the Sleep Aids market amounts to US$92.48m in 2024. The market is expected to grow annually by 0.20% (CAGR 2024-2028).
  • In global comparison, most revenue is generated in the United States (US$2,103m in 2024).
  • In relation to total population figures, per person revenues of US$0.15 are generated in 2024.

Key regions: Thailand, Indonesia, United States, Europe, Philippines

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Sleep Aids market in LATAM is showing significant growth due to changing customer preferences, emerging trends in the market, local special circumstances, and underlying macroeconomic factors.

Customer preferences:
Customers in LATAM are increasingly valuing their sleep and recognizing the importance of a good night's rest for their overall well-being. As a result, there is a growing demand for sleep aids that can help improve sleep quality and address common sleep issues such as insomnia and sleep apnea. Additionally, consumers are becoming more health-conscious and are seeking natural and organic sleep aids that are free from harmful chemicals and have minimal side effects.

Trends in the market:
One of the key trends in the Sleep Aids market in LATAM is the rising popularity of herbal and natural sleep aids. Customers are gravitating towards products that contain natural ingredients such as chamomile, lavender, and valerian root, as they are believed to have calming and sleep-inducing properties. This trend is driven by the increasing awareness of the potential side effects associated with synthetic sleep aids and the desire for more holistic and sustainable solutions. Another trend in the market is the growing availability and accessibility of sleep aids. With the rise of e-commerce and online platforms, customers in LATAM now have access to a wide range of sleep aids from both local and international brands. This has increased competition in the market and has led to more affordable and diverse options for customers to choose from.

Local special circumstances:
LATAM has a diverse population with different cultural beliefs and practices related to sleep. For example, in some countries, it is common for people to take afternoon siestas or naps, which can affect their sleep patterns and may lead to the need for sleep aids to regulate their sleep-wake cycle. Additionally, the prevalence of stress and anxiety in the region can contribute to sleep disorders, further driving the demand for sleep aids.

Underlying macroeconomic factors:
LATAM has experienced economic growth in recent years, leading to an increase in disposable income and a higher standard of living for many consumers. This has allowed more people to afford sleep aids and prioritize their sleep health. Additionally, the aging population in LATAM is driving the demand for sleep aids, as older individuals are more likely to experience sleep problems and are willing to invest in products that can improve their sleep quality. In conclusion, the Sleep Aids market in LATAM is growing due to changing customer preferences, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. Customers are increasingly valuing their sleep and seeking natural and accessible sleep aids. The availability of a wide range of products online has also contributed to the market growth. Additionally, cultural beliefs and practices related to sleep and the region's economic growth and aging population have further fueled the demand for sleep aids.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)